Wall Street Analysts Are Bullish on Top Healthcare Picks
Jefferies Downgrades Pro Medicus to Hold From Buy; Price Target Is AU$120
Pro Medicus Price Target Raised 9% to A$148.00/Share by Goldman Sachs
CLSA Upgrades Pro Medicus to Accumulate From Reduce, Price Target Is AU$125
No Data
No Data